Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

RxSight (RXST) EBT Margin (2020 - 2025)

RxSight's EBT Margin history spans 6 years, with the latest figure at 28.05% for Q4 2025.

  • For Q4 2025, EBT Margin fell 8147.0% year-over-year to 28.05%; the TTM value through Dec 2025 reached 28.91%, down 2891.0%, while the annual FY2025 figure was 28.91%, 2891.0% down from the prior year.
  • EBT Margin reached 28.05% in Q4 2025 per RXST's latest filing, up from 32.32% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 391.19% in Q4 2021 to a low of 275.15% in Q2 2021.
  • Average EBT Margin over 5 years is 61.59%, with a median of 45.41% recorded in 2023.
  • The largest YoY upside for EBT Margin was 67041bps in 2021 against a maximum downside of -95464bps in 2021.
  • A 5-year view of EBT Margin shows it stood at 391.19% in 2021, then tumbled by -125bps to 97.0% in 2022, then surged by 67bps to 32.18% in 2023, then surged by 266bps to 53.41% in 2024, then plummeted by -153bps to 28.05% in 2025.
  • Per Business Quant, the three most recent readings for RXST's EBT Margin are 28.05% (Q4 2025), 32.32% (Q3 2025), and 34.94% (Q2 2025).